Study Details: COTC trial, this trial is to investigate the use of iniparib, a drug used to treat various cancers in humans and in dogs.
Tumor: soft tissue sarcoma, oral melanoma, carcinoma of head, neck and mammary.
Purpose of study: COTC trial in soft tissue sarcomas, oral melanomas, head and neck carcinomas, and mammary carcinomas: Multiple visits to the hospital are required for drug administration and serial blood and tumor samples over the course of 15-22 days. At the end of the study, $1000 is credited to your pet’s account in order to further treat the tumor.
- For more information: contact Annette Smith, D.V.M., Oncology Service Director, Department of Clinical Sciences. 334-844-4690